Before the development of a formal VTE prophylaxis program, we needed to assess our current compliance with VTE prophylaxis, as the data from 2003 were not recent enough to accurately reflect current ...
The earliest published study on this topic was a retrospective case–control study by Northup and associates [8] focusing on 113 inpatients with cirrhosis who had newly diagnosed VTE during hospital ...
Venous thromboembolism (VTE) remains a significant cause of morbidity and mortality among hospitalised medical patients. Ongoing efforts to refine risk assessment and optimise prophylactic strategies ...
Although acute severe ulcerative colitis (ASUC) is recognized as a life-threatening flare associated with elevated thrombotic risk, the extent and duration of hypercoagulability after hospital ...
Please provide your email address to receive an email when new articles are posted on . The proportion of patients receiving low-dose aspirin increased from 7.65% in 2012 to 55.29% in 2022. A low-dose ...
Hosted on MSN
Low-dose apixaban comparable to full dose for preventing venous thromboembolism recurrence in patients with cancer
Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least six months, followed by an additional 12 months of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback